Eckert & Ziegler SE/€EUZ
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Eckert & Ziegler SE
Eckert & Ziegler SE is a company operating in the pharmaceuticals industry, particularly specializing in the field of medical technology. It focuses on the development, production, and distribution of radioisotopes used for medical imaging, cancer treatment, and industrial applications. Some of its key products include low and high-energy sources used in brachytherapy and calibration sources for imaging devices. Founded in 1997, the company is headquartered in Berlin, Germany. Eckert & Ziegler SE leverages its technical expertise and regulatory experience to deliver specialized solutions, positioning itself as a critical provider in the healthcare and radiation therapy sectors.
Ticker
€EUZ
Sector
Primary listing
XETRA
Employees
1,100
Headquarters
Website
EUZ Metrics
BasicAdvanced
€961m
19.52
€0.79
1.48
€0.17
1.08%
Price and volume
Market cap
€961m
Beta
1.48
52-week high
€23.25
52-week low
€13.33
Average daily volume
26k
Dividend rate
€0.17
Financial strength
Current ratio
3.412
Quick ratio
2.663
Long term debt to equity
12.454
Total debt to equity
16.045
Dividend payout ratio (TTM)
21.09%
Interest coverage (TTM)
15.90%
Profitability
EBITDA (TTM)
90.51
Gross margin (TTM)
48.91%
Net profit margin (TTM)
15.61%
Operating margin (TTM)
24.12%
Effective tax rate (TTM)
32.16%
Revenue per employee (TTM)
€290,000
Management effectiveness
Return on assets (TTM)
10.29%
Return on equity (TTM)
19.84%
Valuation
Price to earnings (TTM)
19.517
Price to revenue (TTM)
3.046
Price to book
3.58
Price to tangible book (TTM)
4.35
Price to free cash flow (TTM)
32.301
Free cash flow yield (TTM)
3.10%
Free cash flow per share (TTM)
0.477
Dividend yield (TTM)
1.08%
Forward dividend yield
1.08%
Growth
Revenue change (TTM)
6.84%
Earnings per share change (TTM)
43.24%
3-year revenue growth (CAGR)
11.21%
10-year revenue growth (CAGR)
8.38%
3-year earnings per share growth (CAGR)
21.47%
10-year earnings per share growth (CAGR)
16.89%
3-year dividend per share growth (CAGR)
9.69%
10-year dividend per share growth (CAGR)
15.97%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
FAQs